Davita Healthcare (DVA) closed its recent trading session at $139.43, showing a change of -1.23% from the previous day's closing price. The stock changes were less than the S&P 500's daily gain of 0.14%. Meanwhile, the Dow recorded a loss of 0.04%, while the technology-centric Nasdaq rose by 0.38%.
Prior to today's trading, the renal dialysis provider stock took 3.08%, surpassing the healthcare sector's 1.94% loss, delaying the S&P 500's 5.35% profit.
The investment community will pay close attention to Davita Healthcare's revenue performance in future releases. The company plans to reveal its revenue on August 5, 2025. Our earnings per share (EPS) is projected to be $2.7, reflecting an increase of 4.25% from the same period last year. Meanwhile, Zacks Consensus estimates net sales of $3.3 billion, up 3.5% from the same period last year.
Zacks Consensus estimates that earnings of $10.76 per share and revenue of $13.48 billion over the yearly period, showing a shift of +11.16% and +5.15% from last year, respectively.
Recent changes to Davita Healthcare analyst estimates also need to be eyeing investors. These recent revisions usually mean changing landscapes of short-term business trends. Therefore, a positive revision of the estimate conveys the analyst's confidence in business performance and potential profits.
Research shows that these estimated revisions are directly correlated with short-term stock price momentum. To exploit this, we formed a Zacks rank, which is a quantitative model that includes these estimation changes and presents a viable evaluation system.
The range of Zacks ranked systems ranges from #1 (strong purchase) to #5 (strong cell). It has an incredible track record of externally audited success, with #1 shares supplying an average annual return rate of +25% since 1988. Within the last 30 days, our consensus EPS forecasts remained stagnant. Currently, Davita Healthcare has a #3 (hold) Zacks rank.
Looking at the ratings, Davita Healthcare retains a forward P/E ratio of 13.13. This shows a discount on the industry average forward P/E of 17.82.
Additionally, it should be noted that DVA currently holds a PEG ratio of 0.97. The PEG ratio is similar to the commonly used P/E ratio, but this measure also incorporates the expected revenue growth rate. Healthcare – The outpatient and home healthcare industries averaged PEG ratio of 1.63, as trade closed yesterday.
The story continues
